These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20338480)

  • 1. Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation.
    McGee MC; Hamner JB; Williams RF; Rosati SF; Sims TL; Ng CY; Gaber MW; Calabrese C; Wu J; Nathwani AC; Duntsch C; Merchant TE; Davidoff AM
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1537-45. PubMed ID: 20338480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-beta restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiation.
    Sims TL; McGee M; Williams RF; Myers AL; Tracey L; Hamner JB; Ng C; Wu J; Gaber MW; McCarville B; Nathwani AC; Davidoff AM
    Mol Cancer Ther; 2010 Mar; 9(3):761-71. PubMed ID: 20197402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation.
    Myers AL; Williams RF; Ng CY; Hartwich JE; Davidoff AM
    J Pediatr Surg; 2010 Jun; 45(6):1080-5. PubMed ID: 20620299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy.
    Dickson PV; Hamner JB; Sims TL; Fraga CH; Ng CY; Rajasekeran S; Hagedorn NL; McCarville MB; Stewart CF; Davidoff AM
    Clin Cancer Res; 2007 Jul; 13(13):3942-50. PubMed ID: 17606728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts.
    Pinel S; Barberi-Heyob M; Cohen-Jonathan E; Merlin JL; Delmas C; Plenat F; Chastagner P
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):250-9. PubMed ID: 15093922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic therapy: a novel approach to overcome tumor hypoxia.
    Peng F; Chen M
    Chin J Cancer; 2010 Aug; 29(8):715-20. PubMed ID: 20663317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.
    Vangestel C; Van de Wiele C; Van Damme N; Staelens S; Pauwels P; Reutelingsperger CP; Peeters M
    J Nucl Med; 2011 Nov; 52(11):1786-94. PubMed ID: 22045708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin-induced tumor vasculature remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation.
    Myers AL; Orr WS; Denbo JW; Ng CY; Zhou J; Spence Y; Wu J; Davidoff AM
    J Pediatr Surg; 2012 Jan; 47(1):183-9. PubMed ID: 22244414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy.
    Vistica DT; Hollingshead M; Borgel SD; Kenney S; Stockwin LH; Raffeld M; Schrump DS; Burkett S; Stone G; Butcher DO; Shoemaker RH
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):561-70. PubMed ID: 19636271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.
    Dings RP; Loren M; Heun H; McNiel E; Griffioen AW; Mayo KH; Griffin RJ
    Clin Cancer Res; 2007 Jun; 13(11):3395-402. PubMed ID: 17545548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.
    Rapisarda A; Hollingshead M; Uranchimeg B; Bonomi CA; Borgel SD; Carter JP; Gehrs B; Raffeld M; Kinders RJ; Parchment R; Anver MR; Shoemaker RH; Melillo G
    Mol Cancer Ther; 2009 Jul; 8(7):1867-77. PubMed ID: 19584228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturation of tumor vasculature by interferon-beta disrupts the vascular niche of glioma stem cells.
    Williams RF; Sims TL; Tracey L; Myers AL; Ng CY; Poppleton H; Nathwani AC; Davidoff AM
    Anticancer Res; 2010 Sep; 30(9):3301-8. PubMed ID: 20944101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab.
    Yadav VN; Altshuler D; Kadiyala P; Zamler D; Comba A; Appelman H; Dunn P; Koschmann C; Castro MG; Löwenstein PR
    Neuro Oncol; 2018 Sep; 20(10):1356-1367. PubMed ID: 29660022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous delivery of IFN-beta promotes sustained maturation of intratumoral vasculature.
    Dickson PV; Hamner JB; Streck CJ; Ng CY; McCarville MB; Calabrese C; Gilbertson RJ; Stewart CF; Wilson CM; Gaber MW; Pfeffer LM; Skapek SX; Nathwani AC; Davidoff AM
    Mol Cancer Res; 2007 Jun; 5(6):531-42. PubMed ID: 17579115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
    Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC
    Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy.
    Bhuvaneswari R; Thong PS; Gan YY; Soo KC; Olivo M
    J Biomed Opt; 2010; 15(1):011114. PubMed ID: 20210440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
    Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
    Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic approaches to malignant gliomas.
    Soffietti R; Trevisan E; Bertero L; Bosa C; Ruda R
    Curr Cancer Drug Targets; 2012 Mar; 12(3):279-88. PubMed ID: 22229250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model.
    Mathieu V; De Nève N; Le Mercier M; Dewelle J; Gaussin JF; Dehoux M; Kiss R; Lefranc F
    Neoplasia; 2008 Dec; 10(12):1383-92. PubMed ID: 19048117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.